TCM
WST icon

Tuttle Capital Management’s West Pharmaceutical WST Stock Holding History

Tuttle Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,401
Closed -$1.95M – 252
2019
Q3 		$1.95M Buy
+13,401
New +$1.85M 0.52% 61

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Tuttle Capital Management's WST Position: Q4 2019 in Review

Tuttle Capital Management sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 13,401 shares — an estimated $1.95M sold.

Tuttle Capital Management first reported a position in WST in Q3 2019 and held it in 1 quarter. The position peaked at $1.95M in Q3 2019. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • Tuttle Capital Management reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • Tuttle Capital Management sold 13,401 West Pharmaceutical shares in Q4 2019, an estimated $1.95M.
  • Tuttle Capital Management first reported a position in West Pharmaceutical in Q3 2019 and held it in 1 quarter.
  • Tuttle Capital Management's West Pharmaceutical position peaked at $1.95M in Q3 2019.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on Tuttle Capital Management's 13F filing for Q4 2019, filed 13 Jan 2020.